FDA Warning Letter — Missouri Analytical Laboratories, Inc.

Case 615319 — FEI 1946524

The FDA took a Warning Letter action against Missouri Analytical Laboratories, Inc. on September 30, 2021 (Saint Louis, MO). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Missouri Analytical Laboratories, Inc.
Date
September 30, 2021
Fiscal Year
2021
Product Type
Drugs
Center
CDER
Location
Saint Louis, MO (United States)